title: Antigens recognized on human tumors by cytolytic T lymphocytes: towards vaccination?
abstract: It has been known for many years that cytolytic T lymphocytes that specifically recognize the tumor cells of the same patient can be derived from the blood of melanoma patients. Several of the antigens recognized by these antitumor T lymphocytes have now been completely identified. Some of them are sufficiently tumor-specific to envision their use as antitumor vaccines in selected cancer patients.
authors.affiliation: Ludwig Institute for Cancer Research, Brussels Branch, Belgium.
authors.forename: P G
authors.initials: PG
authors.lastname: Coulie
mesh_terms: D000951:Antigens, Neoplasm / Q000235:genetics; D001324:Autoantigens; D006801:Humans; D007167:Immunotherapy; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy*; D009857:Oncogenes; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D014611:Vaccination
chemical_list: D000951:Antigens, Neoplasm; D001324:Autoantigens